Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Grant or award Director acquired 1,155 shares (grant or award)
  2. 4 Grant or award Director acquired 1,155 shares (grant or award)
  3. 4 Grant or award Director acquired 1,905 shares (grant or award)
  4. 4 Grant or award Director acquired 1,155 shares (grant or award)
  5. 4 Grant or award Director acquired 1,155 shares (grant or award)
  6. 4 Grant or award Director acquired 1,155 shares (grant or award)
  7. 4 Grant or award Director acquired 1,155 shares (grant or award)
  8. 4 Grant or award Director acquired 1,155 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 4 Shares withheld for taxes EVP, Research and Development gave up 960 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Executive Officer gave up 658 shares (to pay taxes)
  13. 4 Open-market buy Director bought 118,342 shares at an average $229.94 ($27,211,824)
  14. 4 Open-market buy Chief Executive Officer bought 4,351 shares at $231.48 ($1,007,169)
  15. 4 Open-market sale Director sold 6,114 shares at $328.55 ($2,008,755)
  16. 4 Shares withheld for taxes EVP Pharmaceutical Oper & Tech gave up 658 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP Chief Legal Officer & Sec. gave up 4,109 shares (to pay taxes)
  18. 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 739 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Executive Officer gave up 2,340 shares (to pay taxes)
  20. 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 586 shares (to pay taxes)

Page 18 of 86 · 1,714 filings